These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2654849)

  • 1. Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial.
    Pan SH; Canafax DM; Le CT; Cipolle RJ; Uden DL; Warwick WJ
    Pediatr Pulmonol; 1989; 6(3):172-9. PubMed ID: 2654849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of theophylline on lung function tests, sleep quality, and nighttime SaO2 in children with cystic fibrosis.
    Avital A; Sanchez I; Holbrow J; Kryger M; Chernick V
    Am Rev Respir Dis; 1991 Dec; 144(6):1245-9. PubMed ID: 1741534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
    Shapiro GG; Bamman J; Kanarek P; Bierman CW
    Pediatrics; 1976 Nov; 58(5):740-3. PubMed ID: 790287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S; Zielen S
    Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous aminophylline in patients with cystic fibrosis. Pharmacokinetics and effect on pulmonary function.
    Larsen GL; Barron RJ; Landay RA; Cotton EK; Gonzalez MA; Brooks JG
    Am J Dis Child; 1980 Dec; 134(12):1143-8. PubMed ID: 7446501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.
    Elborn JS; Ramsey BW; Boyle MP; Konstan MW; Huang X; Marigowda G; Waltz D; Wainwright CE;
    Lancet Respir Med; 2016 Aug; 4(8):617-626. PubMed ID: 27298017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline disposition in cystic fibrosis.
    Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S
    Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
    Knoppert DC; Spino M; Beck R; Thiessen JJ; MacLeod SM
    Clin Pharmacol Ther; 1988 Sep; 44(3):254-64. PubMed ID: 3046811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral theophylline disposition in cystic fibrosis.
    Georgitis JW; Eigen H; Warner R; Gonzales MA
    Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized study of sodium cromoglycate versus placebo in patients with cystic fibrosis and bronchial hyperreactivity.
    Sivan Y; Arce P; Eigen H; Nickerson BG; Newth CJ
    J Allergy Clin Immunol; 1990 Mar; 85(3):649-54. PubMed ID: 2107242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.
    Davies J; Sheridan H; Bell N; Cunningham S; Davis SD; Elborn JS; Milla CE; Starner TD; Weiner DJ; Lee PS; Ratjen F
    Lancet Respir Med; 2013 Oct; 1(8):630-638. PubMed ID: 24461666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased physiological dead space during exercise after bronchodilation in cystic fibrosis.
    Kusenbach G; Friedrichs F; Skopnik H; Heimann G
    Pediatr Pulmonol; 1993 May; 15(5):273-8. PubMed ID: 8327285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR; Dull WL; Kasik JE
    JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.